Canmax Technologies (300390) Q4 2025 earnings summary

Executive summary

• Revenue for 2025 reached ¥7.55 billion, up 14.23% year-over-year, with net profit attributable to shareholders at ¥402 million, down 51.77% year-over-year.

• Gross margin for lithium battery materials was 13.62%, with the segment contributing 86.08% of total revenue.

• The company maintained leading positions in lithium battery materials, anti-static clean technology, and medical devices, with significant R&D and global resource integration.

• No cash dividend, bonus shares, or capital reserve to share capital conversion was proposed for 2025.

Financial highlights

• Operating income: ¥7.55 billion, up 14.23% year-over-year.

• Net profit attributable to shareholders: ¥402 million, down 51.77% year-over-year.

• Basic and diluted EPS: ¥0.48, down 52% year-over-year.

• Operating cash flow: -¥322 million, compared to +¥1.47 billion last year.

• Total assets: ¥23.09 billion, up 19.80% year-over-year.

• Net assets attributable to shareholders: ¥11.35 billion, down 9.43% year-over-year.

Outlook and guidance

• Plans to expand lithium battery material capacity, strengthen upstream resource control, and deepen global market presence.

• Focus on R&D for next-generation battery materials, anti-static technology, and high-end medical devices.

• 2026 strategy includes digital transformation, cost control, and further ESG integration.